Neil S. Sadick
Experienced in Atopic Dermatitis

Dr. Neil S. Sadick

Dermatology
Northwell Health
911 Park Avenue, Apartment 1A, 
New York, NY 
On Staff At
Experienced in Atopic Dermatitis
Northwell Health
911 Park Avenue, Apartment 1A, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Neil Sadick is a Dermatologist in New York, New York. Dr. Sadick is rated as an Experienced provider by MediFind in the treatment of Atopic Dermatitis. His top areas of expertise are Acne, Autosomal Recessive Hypotrichosis, Melasma, and Rosacea.

His clinical research consists of co-authoring 122 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 5 clinical trials in the study of Atopic Dermatitis.

Graduate Institution
Upstate Medical University: College Of Health Professions
Specialties
Dermatology
Licenses
Dermatology in NY
Hospital Affiliations
North Shore University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

911 Park Avenue, Apartment 1A, New York, NY 10075

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
Open-label, Prospective, Multicenter Study to Evaluate the Cutera enLighten™ Laser and a Micro-Lens Array Handpiece Attachment for the Treatment of Moderate and Severe Acne Scars
Open-label, Prospective, Multicenter Study to Evaluate the Cutera enLighten™ Laser and a Micro-Lens Array Handpiece Attachment for the Treatment of Moderate and Severe Acne Scars
Enrollment Status: Completed
Publish Date: August 01, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Pivotal USA Randomized, Evaluator-blinded, Active-controlled, Multi-center, Split-face Comparison Study of Emervel Classic Lidocaine Versus Juvederm® Ultra in the Treatment of Moderate to Severe Facial Wrinkle Folds
A Pivotal USA Randomized, Evaluator-blinded, Active-controlled, Multi-center, Split-face Comparison Study of Emervel Classic Lidocaine Versus Juvederm® Ultra in the Treatment of Moderate to Severe Facial Wrinkle Folds
Enrollment Status: Completed
Publish Date: July 25, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: November 30, 2022
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 09, 2022
Intervention Type: Other, Biological
Study Drugs: Lebrikizumab, Topical Corticosteroid
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 04, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
Enrollment Status: Completed
Publish Date: November 20, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
Study to Evaluate Safety and Efficacy of a Nutraceutical Supplement With Standardized Botanicals for Treatment of Hair Loss and Thinning in Females
Study to Evaluate Safety and Efficacy of a Nutraceutical Supplement With Standardized Botanicals for Treatment of Hair Loss and Thinning in Females
Enrollment Status: Completed
Publish Date: January 02, 2019
Intervention Type: Dietary supplement
Study Phase: Not Applicable
View 9 Less Clinical Trials

122 Total Publications

Caffeine Supplementation and Hair: A Systematic Review.
Caffeine Supplementation and Hair: A Systematic Review.
Journal: Journal of drugs in dermatology : JDD
Published: November 04, 2025
View All 122 Publications
Similar Doctors
Elite in Atopic Dermatitis
Dr. Mark G. Lebwohl
Dermatology
Elite in Atopic Dermatitis
Dr. Mark G. Lebwohl
Dermatology
5 E 98th St, 5th Floor Box 1048, 
New York, NY 
 (0.9 miles away)
212-241-5778
Languages Spoken:
English
See accepted insurances

Mark Lebwohl is a Dermatologist in New York, New York. Dr. Lebwohl is rated as an Elite provider by MediFind in the treatment of Atopic Dermatitis. His top areas of expertise are Plaque Psoriasis, Psoriasis, Pustular Psoriasis, and Generalized Pustular Psoriasis (GPP).

Elite in Atopic Dermatitis
Dr. Patrick M. Brunner
Dermatology
Elite in Atopic Dermatitis
Dr. Patrick M. Brunner
Dermatology

Icahn School Of Medicine At Mount Sinai

1 Gustave Levy Place, 
New York, NY 
 (1.0 miles away)
212-241-8234
Languages Spoken:
English
See accepted insurances

Patrick Brunner is a Dermatologist in New York, New York. Dr. Brunner is rated as a Distinguished provider by MediFind in the treatment of Atopic Dermatitis. His top areas of expertise are Atopic Dermatitis, Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), and Parapsoriasis.

Distinguished in Atopic Dermatitis
Dr. Andrew F. Alexis
Dermatology
Distinguished in Atopic Dermatitis
Dr. Andrew F. Alexis
Dermatology

Weill Medical College Of Cornell

525 E 68th St, 
New York, NY 
 (0.9 miles away)
212-746-5454
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Andrew Alexis is a Dermatologist in New York, New York. Dr. Alexis is rated as an Elite provider by MediFind in the treatment of Atopic Dermatitis. His top areas of expertise are Acne, Melasma, Atopic Dermatitis, and Vitiligo.

VIEW MORE ATOPIC DERMATITIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sadick's expertise for a condition
ConditionClose
    • Distinguished
    • Acne
      Dr. Sadick is
      Distinguished
      . Learn about Acne.
      See more Acne experts
    • Autosomal Recessive Hypotrichosis
      Dr. Sadick is
      Distinguished
      . Learn about Autosomal Recessive Hypotrichosis.
      See more Autosomal Recessive Hypotrichosis experts
    • Melasma
      Dr. Sadick is
      Distinguished
      . Learn about Melasma.
      See more Melasma experts
      • Experienced
      • Alopecia Areata
        Dr. Sadick is
        Experienced
        . Learn about Alopecia Areata.
        See more Alopecia Areata experts
      • Atopic Dermatitis
        Dr. Sadick is
        Experienced
        . Learn about Atopic Dermatitis.
        See more Atopic Dermatitis experts
      • Livedo Reticularis
        Dr. Sadick is
        Experienced
        . Learn about Livedo Reticularis.
        See more Livedo Reticularis experts
      • Liver Spots
        Dr. Sadick is
        Experienced
        . Learn about Liver Spots.
        See more Liver Spots experts
      • Psoriasis
        Dr. Sadick is
        Experienced
        . Learn about Psoriasis.
        See more Psoriasis experts
      • Pustules
        Dr. Sadick is
        Experienced
        . Learn about Pustules.
        See more Pustules experts
      View All 8 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

          Close
          0 / 1000

          Please provide us with the below insurance information:

                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.